Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

I hope that comes to fruition Ville!

Then i will reduce further and slowly and step by step say good bye

Because that means things are going good. Regarding

hopefully positive topline data in SPI-2012/eflapegrastim

Regarding Rolontis, my concerns are different than yours. I see positive topline data as a gimmie, my concern, as discussed previously, is the wait till the end of the year to submit the BLA. Definitely a slower approval process than expected. The other thing about Rolontis is that I think, for the most part, it is a 'show me' drug in that the street will only get a little excited w topline data (since to me it's a gimmie). Analysts will want to see some positive sales to really get excited about Rolontis to confirm the hype is not BS. Hope I'm wrong on that. I think much of the driver to the next SP level next year will be Pozi driven.